↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$366KSold on the market
1Companies
Oct 19, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:49 | Oct 15, 2026 | ARQTArcutis Biotherapeutics, Inc. | Director | S · Sell10b5-1 | $26.93 | −4,728 | 35,207 | -12% | −$127K | ||
| Oct 19, 202616:49 | Oct 15, 2026 | ARQTArcutis Biotherapeutics, Inc. | Director | M · Exercise10b5-1 | $7.93 | +4,094 | 39,935 | +11% | $32K | ||
| Sep 17, 202616:06 | Sep 15, 2026 | ARQTArcutis Biotherapeutics, Inc. | Director | S · Sell10b5-1 | $24.18 | −4,730 | 35,841 | -12% | −$114K | ||
| Sep 17, 202616:06 | Sep 15, 2026 | ARQTArcutis Biotherapeutics, Inc. | Director | M · Exercise10b5-1 | $7.93 | +4,096 | 40,571 | +11% | $32K | ||
| Aug 19, 202616:57 | Aug 17, 2026 | ARQTArcutis Biotherapeutics, Inc. | Director | S · Sell10b5-1 | $26.18 | −4,730 | 36,475 | -11% | −$124K | ||
| Aug 19, 202616:57 | Aug 17, 2026 | ARQTArcutis Biotherapeutics, Inc. | Director | M · Exercise10b5-1 | $7.93 | +4,096 | 41,205 | +11% | $32K |